TTD | Drug: D06TVS

Drug General Information
Drug ID	D06TVS
Former ID	DNC013251
Drug Name	N1-benzyl-N3-hydroxy-2-isobutylmalonamide
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[528501]
Structure		Download 2D MOL 3D MOL
Formula	C14H20N2O3
Canonical SMILES	CC(C)CC(C(=O)NCC1=CC=CC=C1)C(=O)NO
InChI	1S/C14H20N2O3/c1-10(2)8-12(14(18)16-19)13(17)15-9-11-6-4-3-5-7-11/h3-7,10,12,19H,8-9H2,1-2H3,(H,15,17)(H,16,18)
InChIKey	BOQZRPQZGWWCDJ-UHFFFAOYSA-N
PubChem Compound ID	16116576
Target and Pathway
Target(s)	Aminopeptidase N	Target Info	Inhibitor	[528501]
BioCyc Pathway	Glutathione-mediated detoxification
KEGG Pathway	Glutathione metabolism
	Metabolic pathways
	Renin-angiotensin system
	Hematopoietic cell lineage
Pathway Interaction Database	C-MYB transcription factor network
PathWhiz Pathway	Glutathione Metabolism
Reactome	Metabolism of Angiotensinogen to Angiotensins
WikiPathways	Metabolism of Angiotensinogen to Angiotensins
	Cardiac Progenitor Differentiation
	miR-targeted genes in squamous cell - TarBase
	miR-targeted genes in muscle cell - TarBase
	miR-targeted genes in lymphocytes - TarBase
	miR-targeted genes in leukocytes - TarBase
	Glutathione metabolism
References
Ref 528501	Bioorg Med Chem. 2007 Jan 1;15(1):63-76. Epub 2006 Oct 12.A library of novel hydroxamic acids targeting the metallo-protease family: design, parallel synthesis and screening.
Ref 528501	Bioorg Med Chem. 2007 Jan 1;15(1):63-76. Epub 2006 Oct 12.A library of novel hydroxamic acids targeting the metallo-protease family: design, parallel synthesis and screening.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information